Amoxicillin

Also known as: Amoxycillin

Therapeutic indications

Amoxicillin is indicated for:

Acute bacterial sinusitis

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acute bacterial sinusitis
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 250-1000mg 3 times a day

Treatment 2: Oral - 750-1000mg 2 times a day

Treatment 3: Intravenous - 0.75-2gr 3 times a day

Treatment 4: Intravenous - 2gr 2 times a day

Treatment 5: Intramuscular - 0.75-1gr 3 times a day

Acute pyelonephritis

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acute pyelonephritis
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 250-1000mg 3 times a day

Treatment 2: Oral - 750-1000mg 2 times a day

Treatment 3: Intravenous - 0.75-2gr 3 times a day

Treatment 4: Intravenous - 2gr 2 times a day

Treatment 5: Intramuscular - 0.75-1gr 3 times a day

Dental abscess with spreading cellulitis

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Dental abscess
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 250-1000mg 3 times a day

Treatment 2: Oral - 750-1000mg 2 times a day

Treatment 3: Intravenous - 0.75-2gr 3 times a day

Treatment 4: Intravenous - 2gr 2 times a day

Treatment 5: Intramuscular - 0.75-1gr 3 times a day

Asymptomatic bacteriuria in pregnancy

Population group: women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Asymptomatic bacteriuria in pregnancy
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 250-1000mg 3 times a day

Treatment 2: Oral - 750-1000mg 2 times a day

Acute cystitis

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acute cystitis
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 250-1000mg 3 times a day

Treatment 2: Oral - 750-1000mg 2 times a day

Treatment 3: Oral - 3gr 2 times a day

Treatment 4: Intravenous - 0.75-2gr 3 times a day

Treatment 5: Intravenous - 2gr 2 times a day

Treatment 6: Intramuscular - 0.75-1gr 3 times a day

Acute otitis media

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acute otitis media
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 0,5-1gr 3 times a day

Treatment 2: Oral - 0,75-1gr 2 times a day

Acute streptococcal tonsillitis and pharyngitis

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Streptococcal tonsillitis

Streptococcal sore throat
and additionally at least one of
Streptococcus agalactiae

Streptococcus pyogenes

Streptococcus agalactiae

Streptococcus, group C

Streptococcus, group G

Streptococcus, viridans group

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 0,5-1gr 3 times a day

Treatment 2: Oral - 0,75-1gr 2 times a day

Acute exacerbations of chronic bronchitis

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Acute exacerbation of chronic bronchitis
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 0,5-1gr 3 times a day

Treatment 2: Oral - 0,75-1gr 2 times a day

Treatment 3: Intravenous - 0.75-2gr 3 times a day

Treatment 4: Intravenous - 2gr 2 times a day

Treatment 5: Intramuscular - 0.75-1gr 3 times a day

Community acquired pneumonia

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Community acquired pneumonia
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 0,5-1gr 3 times a day

Treatment 2: Intravenous - 0.75-2gr 3 times a day

Treatment 3: Intravenous - 2gr 2 times a day

Treatment 4: Intramuscular - 0.75-1gr 3 times a day

Typhoid and paratyphoid fever

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

† Typhoid and paratyphoid fevers
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 0.5-2gr 3 times a day

Prosthetic joint infection

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Infected arthroplasty
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 0,5-1 gr 3 times a day

Treatment 2: Intramuscular - 0.75-1 gr 3 times a day

Treatment 3: Intravenous - 0.75-1 gr 3 times a day

Prophylaxis of endocarditis

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Preventive procedure
and additionally
Endocarditis
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 2gr once

Treatment 2: Intravenous - 2gr once

Helicobacter pylori eradication

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Helicobacter pylori gastrointestinal tract infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 0.75-1gr twice daily

Lyme disease

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Lyme disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 0.5-2gr 3 times a day

Treatment 2: Intravenous - 2gr 3 times a day

Acute bacterial sinusitis

Population group: both men and women, only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Acute bacterial sinusitis
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 20-90 mg/kg/day in 3 divided doses

Treatment 2: Intravenous - 20-200 mg/kg/day in 4 equal divided doses

Acute otitis media

Population group: both men and women, only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Acute otitis media
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 20-90 mg/kg/day in 3 divided doses

Treatment 2: Intravenous - 20-200 mg/kg/day in 4 equal divided doses

Community acquired pneumonia

Population group: both men and women, only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Community acquired pneumonia
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 20-90 mg/kg/day in 3 divided doses

Acute cystitis

Population group: both men and women, only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Acute cystitis
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 20-90 mg/kg/day in 3 divided doses

Acute pyelonephritis

Population group: both men and women, only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Acute pyelonephritis
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 20-90 mg/kg/day in 3 divided doses

Treatment 2: Intravenous - 20-200 mg/kg/day in 4 equal divided doses

Dental abscess with spreading cellulitis

Population group: both men and women, only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Dental abscess
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 20-90 mg/kg/day in 3 divided doses

Treatment 2: Intravenous - 20-200 mg/kg/day in 4 equal divided doses

Acute streptococcal tonsillitis and pharyngitis

Population group: both men and women, only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

at least one of
Streptococcal tonsillitis

Streptococcal sore throat
and additionally at least one of
Streptococcus agalactiae

Streptococcus pyogenes

Streptococcus agalactiae

Streptococcus, group C

Streptococcus, group G

Streptococcus, viridans group

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 40-90 mg/kg/day in 3 divided doses

Treatment 2: Intravenous - 20-200 mg / kg / day in 4 equal divided doses

Typhoid and paratyphoid fever

Population group: both men and women, only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

† Typhoid and paratyphoid fevers

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 100 mg/kg/day in three divided doses

Prophylaxis of endocarditis

Population group: both men and women, only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Preventive procedure
and additionally
Endocarditis
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 50 mg/kg once

Treatment 2: Intravenous - Single dose 50 mg/kg 30-60 minutes before the procedure

Lyme disease

Population group: both men and women, only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Lyme disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 25-100 mg/kg/day in three divided doses

Treatment 2: Intravenous - 25-150 mg / kg / day in 4 divided doses

Endocarditis

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Endocarditis
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Intravenous - 1-2 gr 6 times a day

Bacterial meningitis

Population group: both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Bacterial meningitis
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Intravenous - 1-2gr 6 times a day

Endocarditis

Population group: both men and women, only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Endocarditis
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Intravenous - 100-200 mg/kg/day in 4 equal divided doses

Bacterial meningitis

Population group: both men and women, only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Bacterial meningitis
and additionally at least one of
Amoxicillin susceptible species

Amoxicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Intravenous - 100-200 mg/kg/day in 4 equal divided doses

Medication Recommendation

Receive personalized medication regimen for every patient case

Ask the Reasoner

Related medicines